MR imaging of pancreatic islets: Tracking isolation, transplantation and function

Current Pharmaceutical Design

Volumn 16, Issue 14, 2010, Pages 1582-1594

  Leoni, L ^a   Roman, B B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Beta cell function; Contrast agents; In vivo imaging; Magnetic resonance imaging; Pancreatic islets

Indexed keywords

COPOLYMER; GADOLINIUM PENTETATE; SUPERPARAMAGNETIC IRON OXIDE; TRACER;

ARTICLE; BABOON; BIOLUMINESCENCE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; FLUORESCENCE IMAGING; HUMAN; INSULITIS; KIDNEY; LIVER; LYMPHOCYTIC INFILTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STREPTOZOCIN DIABETES; ANIMAL; LEWIS RAT; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; RATS; RATS, INBRED LEW;

EID: 77956212237     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210791164171     Document Type: Article

References (86)

1. Truong W, Lakey JR, Ryan EA, Shapiro AM. Clinical islet transplantation at the University of Alberta-the Edmonton experience. Clin Transpl 2005; 153-72.
2. Matveyenko AV, Butler PC. Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab 2008; 10 (Suppl 4): 23-31.
3. Junker K, Egeberg J, Kromann H, Nerup J. An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand A 1977; 85(5): 699-706.
4. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC. Modestly increased β-cell apoptosis but no increased β-cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 2007; 50(11): 2323-31.
5. Kloppel G, Drenck CR, Oberholzer M, Heitz PU. Morphometric evidence for a striking &beta-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch A Pathol Anat Histopathol 1984; 403(4): 441-52.
6. Eckhard M, Brandhorst D, Winter D, Jaeger C, Jahr H, Bretzel RG, et al. The role of current product release criteria for identification of human islet preparations suitable for clinical transplantation. Transplant Proc 2004; 36(5): 1528-31.
7. Medarova Z, Moore A. MRI as a tool to monitor islet transplantation. Nat Rev Endocrinol 2009; 5(8): 444-52.
8. Medarova Z, Moore A. MRI in diabetes: first results. AJR Am J Roentgenol 2009; 193(2): 295-303.
9. Gaglia JL. Noninvasive imaging of islet transplantation and rejection. Curr Diabetes Rep 2007; 7(4): 309-13.
10. Malaisse WJ, Louchami K, Sener A. Noninvasive imaging of pancreatic beta cells. Nat Rev Endocrinol 2009; 5(7): 394-400.
11. Medarova Z, Moore A. Non-invasive detection of transplanted pancreatic islets. Diabetes Obes Metab 2008; 10 (Suppl 4): 88-97.
12. Virostko J, Jansen ED, Powers AC. Current status of imaging pancreatic islets. Curr Diabetes Rep 2006; 6(4): 328-32.
13. Souza F, Freeby M, Hultman K, Simpson N, Herron A, Witkowsky P, et al. Current progress in non-invasive imaging of β-cell mass of the endocrine pancreas. Curr Med Chem 2006; 13(23): 2761-73.
14. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982; 31(10): 883-9.
15. Buchwald P, Wang X, Khan A, Bernal A, Fraker C, Inverardi L, et al. Quantitative assessment of islet cell products: estimating the accuracy of the existing protocol and accounting for islet size distribution. Cell Transplant 2009; 18(10): 1223-35.
16. Kaihoh T, Masuda T, Sasano N, Takahashi T. The size and number of Langerhans islets correlated with their endocrine function: a morphometry on immunostained serial sections of adult human pancreases. Tohoku J Exp Med 1986; 149(1): 1-10.
17. Tons HA, Terpstra OT, Bouwman E. Heterogeneity of human pancreata in perspective of the isolation of the islets of langerhans. Transplant Proc 2008; 40(2): 367-9.
18. Toso C, Vallee JP, Morel P, Ris F, Demuylder-Mischler S, Lepetit-Coiffe M, et al. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 2008; 8(3): 701-6.
19. Jirak D, Kriz J, Herynek V, Andersson B, Girman P, Burian M, et al. MRI of transplanted pancreatic islets. Magn Reson Med 2004; 52(6): 1228-33.
20. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004; 39(1): 56-63.
21. Moore A, Grimm J, Han B, Santamaria P. Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time. Diabetes 2004; 53(6): 1459-66.
22. Rogers WJ, Basu P. Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging. Atherosclerosis 2005; 178(1): 67-73.
23. von Zur Muhlen C, von Elverfeldt D, Bassler N, Neudorfer I, Steitz B, Petri-Fink A, et al. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 2007; 193(1): 102-11.
24. Riviere C, Wilhelm C, Cousin F, Dupuis V, Gazeau F, Perzynski R. Internal structure of magnetic endosomes. Eur Phys J E Soft Matter 2007; 22(1): 1-10.
25. Malosio ML, Esposito A, Poletti A, Chiaretti S, Piemonti L, Melzi R, et al. Improving the procedure for detection of intrahepatic transplanted islets by magnetic resonance imaging. Am J Transplant 2009; 9(10): 2372-82.
26. Ris F, Lepetite-Coiffe M, Toso C, Armanet M, Crowe LA, Bosco D, et al. Radio-histological correlation and comparative assessment of iron oxide nanoparticles for islet labeling in human islet graft MRI monitoring. In: Imaging the Pancreatic &beta-Cell, 4th Workshop. Washington, DC 2009.
27. Evgenov NV, Medarova Z, Pratt J, Pantazopoulos P, Leyting S, Bonner-Weir S, et al. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes 2006; 55(9): 2419-28.
28. Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med 2006; 12(1): 144-8.
29. Marzola P, Longoni B, Szilagyi E, Merigo F, Nicolato E, Fiorini S, et al. In vivo visualization of transplanted pancreatic islets by MRI: comparison between in vivo, histological and electron microscopy findings. Contrast Media Mol Imaging 2009; 4(3): 135-42.
30. Ris F, Crowe LA, Morel P, Armanet M, Masson S, Nielles-Vallespin S, et al. Quantification of rransplanted iron oxide labeled islet cells using an ultra short echo time acquisition technique at 3T. In: Imaging the Pancreatic β-Cell, 4th Workshop. Washington, DC 2009.
31. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 2007; 58(4): 725-34.
32. Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET. In vivo cytometry of antigen-specific t cells using 19F MRI. Magn Reson Med 2009; 62(3): 747-53.
33. Biancone L, Crich SG, Cantaluppi V, Romanazzi GM, Russo S, Scalabrino E, et al. Magnetic resonance imaging of gadoliniumlabeled pancreatic islets for experimental transplantation. NMR Biomed 2007; 20(1): 40-8.
34. Medarova Z, Castillo G, Dai G, Bolotin E, Bogdanov A, Moore A. Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes. Diabetes 2007; 56(11): 2677-82.
35. Hathout E, Sowers L, Wang R, Tan A, Mace J, Peverini R, et al. In vivo magnetic resonance imaging of vascularization in islet transplantation. Transplant Int 2007; 20(12): 1059-65.
36. Kohlmeir E, Waters A, Mastarone D, Song Y, Wang L, Kaufman DB, et al. Optimizing Tracking of Transplanted Pancreatic Islets With T1 MR Contrast Agents. In: Imaging the Pancreatic β-Cell, 4th Workshop. Washington, DC 2009.
37. Angtuaco TL, Mattison DR, Thomford PJ, Jordan J. Effect of manganese on human placental spin-lattice (T1) and spin-spin (T2) relaxation times. Physiol Chem Phys Med NMR 1986; 18(1): 41-8.
38. Kang YS, Gore JC. Studies of tissue NMR relaxation enhancement by manganese. Dose and time dependences. Invest Radiol 1984; 19(5): 399-407.
39. Mamourian AC, Burnett KR, Goldstein EJ, Wolf GL, Kressel HY, Baum S. Proton relaxation enhancement in tissue due to ingested manganese chloride: time course and dose response in the rat. Physiol Chem Phys Med NMR 1984; 16(2): 123-8.
40. Mendonca-Dias MH, Gaggelli E, Lauterbur PC. Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Semin Nucl Med 1983; 13(4): 364-76.
41. Wydrzynski TJ, Marks SB, Schmidt PG, Govindjee, Gutowsky HS. Nuclear magnetic relaxation by the manganese in aqueous suspensions of chloroplasts. Biochemistry 1978; 17(11): 2155-62.
42. Lauterbur P, Mendonca-Dias M, Rudin A. Augmentation of tissue water proton spin-lattice relaxation rates by in-vivo addition of paramagnetic ions. Frontiers Biol Energy 1978; 1: 752.
43. Hunter DR, Komai H, Haworth RA, Jackson MD, Berkoff HA. Comparison of Ca2+, Sr2+, and Mn2+ fluxes in mitochondria of the perfused rat heart. Circ Res 1980; 47(5): 721-7.
44. Dryselius S, Grapengiesser E, Hellman B, Gylfe E. Voltagedependent entry and generation of slow Ca2+ oscillations in glucose-stimulated pancreatic &beta-cells. Am J Physiol 1999; 276(3 Pt 1): E512-8.
45. Haque ME, Leoni L, Zuckerman M, Serai SD, Roman BB. Manganese Enhanced magnetic resonance imaging (MEMRI) of endogenous rodent pancreas activation. 2008; in press.
46. Haque ME, Vargas P, Markiewicz E, Dhyani A, Leoni L, La Riviere PJ, et al. High resolution and multisclice functional MRI of pancreatic &beta-cell activation. In: Imaging the Pancreatic &beta-Cell, 4th Workshop 2009; 2009; p. 43.
47. Antkowiak PF, Tersey SA, Carter JD, Vandsburger MH, Nadler JL, Epstein FH, et al. Noninvasive assessment of pancreatic &beta-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am J Physiol Endocrinol Metab 2009; 296(3): E573-8.
48. Gimi B, Leoni L, Oberholzer J, Braun M, Avila J, Wang Y, et al. Functional MR microimaging of pancreatic &beta-cell activation. Cell Transplant 2006; 15(2): 195-203.
49. Leoni L, Dhyani A, La Riviere PJ, Roman BB. ß-cell subcellular localization of glucose stimulated Mn uptake by X-ray fluorescence: implications for pancreatic MRI. In: World Molecular Imaging Conference. Montreal, Canada 2009.
50. Brissova M, Powers AC. Revascularization of transplanted islets: can it be improved? Diabetes 2008; 57(9): 2269-71.
51. Brissova M, Shostak A, Shiota M, Wiebe PO, Poffenberger G, Kantz J, et al. Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function. Diabetes 2006; 55(11): 2974-85.
52. Nyman LR, Wells KS, Head WS, McCaughey M, Ford E, Brissova M, et al. Real-time, multidimensional in vivo imaging used to investigate blood flow in mouse pancreatic islets. J Clin Invest 2008; 118(11): 3790-7.
53. Morini S, Brown ML, Cicalese L, Elias G, Carotti S, Gaudio E, et al. Revascularization and remodelling of pancreatic islets grafted under the kidney capsule. J Anat 2007; 210(5): 565-77.
54. Medarova Z, Evgenov NV, Dai G, Bonner-Weir S, Moore A. In vivo multimodal imaging of transplanted pancreatic islets. Nat Protoc 2006; 1(1): 429-35.
55. Kriz J, Jirak D, Girman P, Berkova Z, Zacharovova K, Honsova E, et al. Magnetic resonance imaging of pancreatic islets in tolerance and rejection. Transplantation 2005; 80(11): 1596-603.
56. Lu Y, Dang H, Middleton B, Zhang Z, Washburn L, Campbell-Thompson M, et al. Bioluminescent monitoring of islet graft survival after transplantation. Mol Ther 2004; 9(3): 428-35.
57. Medarova Z, Vallabhajosyula P, Tena A, Evgenov N, Pantazopoulos P, Tchipashvili V, et al. In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates. Transplantation 2009; 87(11): 1659-66.
58. Fowler M, Virostko J, Chen Z, Poffenberger G, Radhika A, Brissova M, et al. Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation 2005; 79(7): 768-76.
59. Kriz J, Jirak D, White D, Foster P. Magnetic resonance imaging of pancreatic islets transplanted into the right liver lobes of diabetic mice. Transplant Proc 2008; 40(2): 444-8.
60. Tai JH, Foster P, Rosales A, Feng B, Hasilo C, Martinez V, et al. Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla. Diabetes 2006; 55(11): 2931-8.
61. Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci USA 2004; 101(34): 12634-9.
62. Barnett BP, Arepally A, Karmarkar PV, Qian D, Gilson WD, Walczak P, et al. Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med 2007; 13(8): 986-91.
63. Beppu H, Maruta K, Kurner T, Kolb H. Diabetogenic action of streptozotocin: essential role of membrane permeability. Acta Endocrinol (Copenh) 1987; 114(1): 90-5.
64. Kim T, Kim J, Arifin DR, Muja N, Gilad AA, Arepally A, et al. Micorfabrication of multifunctional alginate capsule-in-capsules (CICs) for immunoprotected cell transplantation with MR, CT, and US visibility. Abstract Book - Imaging The Pancreatic &beta-Cell, 4th Workshop. Bethesda, MD 2009.
65. Jirak D, Kriz J, Strzelecki M, Yang J, Hasilo C, White DJ, et al. Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification. Magma 2009; 22(4): 257-65.
66. Henquin JC, Cerasi E, Efendic S, Steiner DF, Boitard C. Pancreatic beta-cell mass or beta-cell function? That is the question! Diabetes Obes Metab 2008; 10 (Suppl 4): 1-4.
67. Lernmark A, Kloppel G, Stenger D, Vathanaprida C, Falt K, Landin-Olsson M, et al. Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch 1995; 425(6): 631-40.
68. Moore A, Sun PZ, Cory D, Hogemann D, Weissleder R, Lipes MA. MRI of insulitis in autoimmune diabetes. Magn Reson Med 2002; 47(4): 751-8.
69. Billotey C, Aspord C, Beuf O, Piaggio E, Gazeau F, Janier MF, et al. T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging. Radiology 2005; 236(2): 579-87.
70. Medarova Z, Tsai S, Evgenov N, Santamaria P, Moore A. In vivo imaging of a diabetogenic CD8+ T cell response during type 1 diabetes progression. Magn Reson Med 2008; 59(4): 712-20.
71. Henderson JR, Moss MC. A morphometric study of the endocrine and exocrine capillaries of the pancreas. Q J Exp Physiol 1985; 70(3): 347-56.
72. Brunicardi FC, Stagner J, Bonner-Weir S, Wayland H, Kleinman R, Livingston E, et al. Microcirculation of the islets of langerhans. long beach veterans administration regional medical education center symposium. Diabetes 1996; 45(4): 385-92.
73. Carlsson PO, Flodstrom M, Sandler S. Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice. Endocrinology 2000; 141(8): 2752-7.
74. Sandler S, Jansson L, Welsh N. Adaptive response in &beta-cell function in pancreatic islets isolated from partially pancreatectomized rats. Mol Cell Endocrinol 1992; 86(3): 149-56.
75. De Paepe ME, Corriveau M, Tannous WN, Seemayer TA, Colle E. Increased vascular permeability in pancreas of diabetic rats: detection with high resolution protein A-gold cytochemistry. Diabetologia 1992; 35(12): 1118-24.
76. Papaccio G. Early insulitis and the islet vascular system. Diabetologia 1993; 36(7): 682-3.
77. Papaccio G. Insulitis and islet microvasculature in type 1 diabetes. Histol Histopathol 1993; 8(4): 751-9.
78. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50(4): 537-44.
79. Turvey SE, Swart E, Denis MC, Mahmood U, Benoist C, Weissleder R, et al. Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest 2005; 115(9): 2454-61.
80. Coenegrachts K, Van Steenbergen W, De Keyzer F, Vanbeckevoort D, Bielen D, Chen F, et al. Dynamic contrast-enhanced MRI of the pancreas: initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging 2004; 20(6): 990-7.
81. Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, et al. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 2009; 29(3): 636-40.
82. Haque ME, Xiaobing F, Markiewicz EJ, Leoni L, Roman BB. Invivo manganese enhanced dynamic magnetic resonance imaging (MEDMRI) to evaluate progression of diabetes in rodent pancreas. proceedings of the 17th Annual Meeting of ISMRM. Honolulu, Hawai'i, USA 2009.
83. Kodama H, Shimojo N, Suzuki KT. Distribution of manganese in rat pancreas and identification of its primary binding protein as procarboxypeptidase B. Biochem J 1991; 278 (Pt 3): 857-62.
84. Dieler AC, Samann PG, Leicht G, Eser D, Kirsch V, Baghai TC, et al. Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): new insights into the functional networks underlying panic attacks as induced by CCK-4. Curr Pharm Des 2008; 14(33): 3492-507.
85. Escobar J, Pereda J, Arduini A, Sandoval J, Sabater L, Aparisi L, et al. Cross-talk between oxidative stress and pro-inflammatory cytokines in acute pancreatitis: a key role for protein phosphatases. Curr Pharm Des 2009; 15(26): 3027-42.
86. Zhang Y, Ruel M, Beanlands RS, deKemp RA, Suuronen EJ, DaSilva JN. Tracking stem cell therapy in the myocardium: applications of positron emission tomography. Curr Pharm Des 2008; 14(36): 3835-53.